Harmony Biosciences Holdings (HRMY)
Operating profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | 190,826 | 175,295 | 178,094 | 203,640 | 192,030 | 199,447 | 146,839 | 133,053 | 120,186 | 101,204 | 110,356 | 100,552 | 87,529 | 66,656 | 55,983 |
Revenue (ttm) | US$ in thousands | 710,199 | 672,548 | 630,000 | 585,184 | 548,499 | 507,747 | 476,532 | 451,378 | 419,060 | 383,158 | 319,980 | 290,957 | 268,890 | 236,824 | 233,336 |
Operating profit margin | 26.87% | 26.06% | 28.27% | 34.80% | 35.01% | 39.28% | 30.81% | 29.48% | 28.68% | 26.41% | 34.49% | 34.56% | 32.55% | 28.15% | 23.99% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $190,826K ÷ $710,199K
= 26.87%
The operating profit margin of Harmony Biosciences Holdings has shown fluctuations over the period from June 30, 2021, to December 31, 2024. The operating profit margin started at 23.99% in June 2021 and gradually increased to reach a peak of 39.28% in September 2023. However, there was a decrease in the operating profit margin in the subsequent periods, with a dip to 26.06% by September 30, 2024.
Overall, the trend indicates fluctuations in operating profit margin performance, with a general increase followed by some variability in the latter periods. This could suggest changes in the company's operating efficiency and effectiveness in generating profits from its operations during the analyzed period.
Peer comparison
Dec 31, 2024